A method of predicting generalization of the process in children and adolescents WITH BONE sarcomas

摘要

method u043fu0440u043eu0433u043du043eu0437u0438u0440u043eu0432u0430u043du0438u00a0 generalization process in children adolescents with u043au043eu0441u0442u043du044bu043cu0438 u0441u0430u0440u043au043eu043cu0430u043cu0438 comprising integrated u043fu0440u043eu0442u0438u0432u043eu043eu043fu0443u0445u043eu043bu0435u0432u043eu0435 treatment and biochemical u0438u0441u0441u043bu0435u0434 u043eu0432u0430u043du0438u0435, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0 orderwhat do patients after u043eu043au043eu043du0447u0430u043du0438u00a0 integrated u043bu0435u0447u0435u043du0438u00a0 with complete clinical and laboratory u0440u0435u043cu0438u0441u0441u0438u0435u0439 u043eu043fu0440u0435u0434u0435u043bu00a0u044eu0442 free fraction of thyroid hormone in the blood content of well u0435u043bu0435u0437u044b u0442u0440u0438u0439u043eu0434u0442u0438u0440u043eu043du0438u043du0430 and its content in the range of from 4.0 to 5.2 u043fu043cu043eu043bu044c / ml predict persistence of remission within 6 to 24 months, and the content of crs u0431u043eu0434u043du043eu0433u043e u0442u0440u0438u0439u043eu0434u0442u0438u0440u043eu043du0438u043du0430 within concentrations from 5.8 to 74 u043fu043cu043eu043bu044c / ml of an u0433u0435u043du0435u0440u0430u043bu0438u0437u0430u0446u0438u044e malignant process in time from 1 to 3 months.